bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.01.16.633337

Using SED-ML for reproducible curation: Verifying BioModels across multiple simulation engines

Abstract

The BioModels Repository contains over 1000 manually curated mechanistic models from published literature, most often encoded in the Systems Biology Markup Language (SBML). This community-based standard formally specifies each model, but does not describe the computational experimental conditions to run a simulation. Therefore, it can be challenging to reproduce any figure or result from a publication with an SBML model alone. The Simulation Experiment Description Markup Language (SED-ML) provides a solution: a standard way to specify exactly how to run an experiment corresponding to a specific figure or result. BioModels was established years before SED-ML, and both systems evolved over time, both in content and acceptance. Hence, only about half of the entries in BioModels contained SED-ML files, and these files reflected the version of SED-ML that was available at the time. Additionally, almost all of these SED-ML files had at least one minor mistake that made them invalid. To make these models and their results more reproducible, we report here on our work updating, correcting and generating new SED-ML files for 1055 curated mechanistic models in BioModels. In addition, because SED-ML is implementation-independent, it can be used for verification, demonstrating that results hold across multiple simulation engines. We tested, corrected, and improved over 450 existing SED-ML files in the BioModels database, and created basic files for the rest of the entries. Then, we used a wrapper architecture for interpreting SED-ML, and report verification results across five different ODE-based biosimulation engines, after further improving the models, the wrappers, and the engines themselves. Our work with SED-ML and the BioModels collection aims to improve the utility of these models by making them more reproducible and credible. Improved reproducibility means these models are now even more fit for re-use, such as in new investigations and as components of multiscale models. Author summaryReproducing computationally-derived scientific results seems like it should be straightforward, but is often elusive. Code is lost, file formats change, and knowledge of what was done is only partially recorded and/or forgotten. Model repositories such as BioModels address this failing in the Systems Biology domain by encoding models in a standard format that can reproduce a figure from the paper from which it was drawn. Here, we delved into the BioModels repository to create and correct the instructions on what to do with every curated model, and then tested those instructions on a variety of simulation platforms, allowing us to find and correct issues with the platforms and the simulators themselves. Not only did this improve the BioModels repository, but also improved the infrastructure necessary to run these verification comparisons in the future, and improved the fitness of the models for re-use by other researchers.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Smith, L. P., Malik-Sherif, R. S., Nguyen, T. V. N., Hermjakob, H., Karr, J., Shaikh, B., Drescher, L., Moraru, I. I., Schaff, J., Agmon, E., Patrie, A., Blinov, M. L., Hellerstein, J., May, E., Nickerson, D., Gennari, J., Sauro, H.. 2025-01-20. Using SED-ML for reproducible curation: Verifying BioModels across multiple simulation engines. https://doi.org/10.1101/2025.01.16.633337

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗